hermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
Kajima Corporation commenced operations in 1840. During this history of about 180 years, Kajima has improved people’s lives by ensuring safety, security and a more rewarding life. We have created numerous social infrastructures including advanced structures, transportation networks, energy facilities and urban complexes. In addition to civil and building construction areas described above, Kajima also provides process engineering services to clients. Numerous EPC and EP/CM projects have been completed, mainly involving facilities for the pharmaceutical, cosmetics and food industries. In Asia, The Company has subsidiary companies in Singapore, Malaysia, Thailand, Vietnam, Philippines, Indonesia, and Myanmar.
USP is an independent non-profit organization that collaborates with the world’s top health and science experts to develop high-quality standards that set the bar for manufacturing and distributing safe and effective medicines, supplements and food around the globe. Two billion people world-wide have access to quality medicines, dietary supplements and food as a result of USP’s standards, advocacy and education.
At USP Biologics our primary objective is to keep you at the vanguard of standards that promote the quality of biological medicines. We do this through our rigorous and proven scientific process. And we place the outcome of our process – the physical standard as well as the method or supporting information– into your hands.
We provide a trusted, independent, single source of reliable standards that are available and used globally. Building upon our successes with more traditional biologics including Insulin and Heparin, we engage with thousands of experts, professionals, associations, regulatory agencies, and companies to pave the way for higher standards for the new wave of biologics and biosimilar drugs. It’s logical really: by actively working with the scientific community and making our rigorously researched standards available to the world, we enable you to provide access to quality medicines for all. Through a collaborative process and commitment to quality, our USP’s biologic standards help by delivering key tools and resources to help make critical medicines, such as the insulin family of products, more accessible to the global population.
To assist you in achieving high standards in drug validation and regulatory compliance as well as avoiding potentially costly mistakes, choose our globally renowned scientific approach that has provided trustworthy standards for decades. Logical really. Our process is as robust as the results you will achieve.
So why not talk with us and find out how we can help advance your biologics and biosimilars project with reliable standards?
XiKang (Wuhan) was founded in 2013, We are One-stop biologics CDMO services supplier, We offers fully integrated CDMO services from cell line development, process/analytical development, drug substance and drug product GMP manufacturing and regulatory affairs.The biologics produced by XiKang have been carried out clinical trials in many countries and regions around the world, including the United States, China, the European Union, Serbia, Russia, Belarus, Australia, India, the Philippines, and Singapore etc.
Regardless of your scientific field, your purpose is to help improve the future of science and ultimately, well-being, to realize life’s potential. At SCIEX, we want to empower and inspire you to break new ground in scientific discovery and diagnostic accuracy. That’s why thousands of life science experts around the world use our innovative technology to make the right decisions quickly. Decisions that positively impact lives.
We pioneer extraordinary solutions in mass spectrometry paired with capillary electrophoresis and liquid chromatography. But we don’t just develop products. It’s what we do together that sets us apart. With our customers and partners, we bring the power of life-changing answers to the questions you have today, and those that you have yet to ask.
With Our Technology, You Can See the Future Differently. As part of the Danaher family of global life science and technology innovators, SCIEX has led the field of mass spectrometry for more than 40 years. From the moment we launched the first ever commercially successful triple quad in 1981, we have continued to develop groundbreaking technologies and solutions that have influenced life-changing research and clinical diagnostic outcomes.
Pall Biotech, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule drugs. The unmatched portfolio of traditional and single-use products is backed by custom service support and is both scalable and easily integrated to support processes from R&D through to commercial phases of production, including formulation/filling. As a core driver of the continuous bioprocessing movement, Pall Biotech has remained focused on delivering innovative semi- and fully continuous solutions, with the goal of continuously improving bioprocesses for a safer, healthier future.
Leading provider of specialized immunology and proteomics services to the biopharmaceutical industry with laboratory facilities located globally. Caprion offers proprietary multiparametric flow cytometry for monitoring of immune responses and mass spectrometry services for quantitative and robust measurement of protein biomarkers across the drug development life cycle.
Japan Bioindustry Association (JBA) is a non-profit organization established in 1987. The organization is planning for sound development in bioscience-related industries and is dedicated to solving problems on a global scale through advances in bioscience. JBA is contributing to society in various areas from the development of advanced technology to the development of industry. Japanese bioindustries have developed with a base in the traditional fermentation industry. However in recent years advances in biotechnology have been made in various fields and this in turn has had an impact on numerous corporations.
JBA’s membership base spans a wide array of corporations that use applications of biotechnology in areas ranging from pharmaceutical and medical supplies, food and cosmetics, as well as chemicals, information, machinery, construction and energy and natural resources. In addition, JBA counts public organizations, universities, public research institutes and a variety of individuals as members. Hence JBA is a unique organization able to comprehensively promote the advancement of bioindustries through the cooperation of industry, academia and government.